StonvexLoading…
StonvexStonvexStonvexCore line items from ALNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $148.00M | $138.91M | $554.48M | $411.12M | $272.38M |
Operating Income | Not available | $9.32M | $43.98M | $32.64M | $20.46M |
Net Income | Not available | $5.36M | $22.03M | $15.65M | $5.62M |
EPS (Diluted) | $0.62 | $0.32 | $1.32 | $0.94 | $0.55 |
Total Assets | Not available | $577.66M | $577.60M | $585.08M | $588.06M |
Total Liabilities | Not available | $271.74M | $276.14M | $290.91M | $299.00M |
Cash & Equivalents | Not available | $41.17M | $40.70M | $39.48M | $49.91M |
Free Cash Flow OCF − CapEx | Not available | $4.00M | $49.69M | $38.03M | $35.25M |
Shares Outstanding | Not available | 17.04M | 16.94M | 16.94M | 16.94M |